Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019

被引:3
|
作者
Wu, Ying [1 ]
Deng, Yujiao [2 ]
Dai, Zhijun [3 ,4 ]
Ma, Yubo [1 ]
Lyu, Lijuan [4 ]
Lei, Chen [5 ]
Zheng, Yi [2 ]
Li, Yizhen [4 ]
Wang, Ziming [1 ,7 ]
Gao, Jie [2 ,6 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Breast Surg, Hangzhou, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China
[5] Ningxia Med Univ, Dept Endocrinol, Gen Hosp, Yinchuan, Peoples R China
[6] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian 710004, Peoples R China
[7] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian 710004, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 15期
关键词
bladder cancer; DALY; death; high fasting plasma glucose; DIABETES-MELLITUS; CIGARETTE-SMOKING; RISK; PREVALENCE; COUNTRIES; CONSUMPTION; MIDDLE;
D O I
10.1002/cam4.6219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. Methods: Bladder cancer data attributable to high FPG were extracted from the Global Burden of Disease Study 2019, and analyzed by age, sex, year, and location. Age-standardized rates were utilized to evaluate the burden between different populations. The temporal trend of the burden was estimated through the Joinpoint analysis. Results: In 2019, high FPG contributed to 22,823.33 (95% uncertainty interval [UI], 4694.88-48,962.26) deaths and 399,654.91 (95% UI, 81,609.35-865,890.95) disability-adjusted life years (DALYs) of bladder cancer globally. Since 1990, the global age-standardized death and DALY rates of bladder cancer attributable to high FPG increased apparently by 39.18% and 41.48%, respectively. During the last 30 years, high FPG-related age-standardized death and DALY rates of bladder cancer have increased in all countries. In 2019, Central Europe showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer, but Andean Latin America had the lowest rates. Nationally, Lebanon showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer in 2019. High FPG-attributable deaths and DALYs of bladder cancer were more considerable among males and older people. Countries with high SDI showed higher levels of age-standardized death and DALY rates of bladder cancer due to high FPG and presented remarkable upward trends in rates in the last 30 years. Conclusions: Globally, the high FPG-associated bladder cancer burden has remarkably increased in all countries, and showed a higher level among countries with higher SDI. Monitoring FPG levels among patients with bladder cancer is critical to lower the corresponding burden.
引用
收藏
页码:16469 / 16481
页数:13
相关论文
共 50 条
  • [41] Burden of Prostate Cancer in China, 1990-2019: Findings From the 2019 Global Burden of Disease Study
    Wang, Fuquan
    Wang, Chenchen
    Xia, Haifa
    Lin, Yun
    Zhang, Dingyu
    Yin, Peng
    Yao, Shanglong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [42] Global burden of disease attributable to high systolic blood pressure in older adults, 1990-2019: an analysis for the Global Burden of Disease Study 2019
    Huang, Yuxian
    Meng, Lingrui
    Liu, Canru
    Liu, Songyue
    Tao, Luqiu
    Zhang, Sijia
    Gao, Jiaying
    Sun, Lingmin
    Qin, Qiying
    Zhao, Yingchen
    Wang, Chang
    Chen, Zihan
    Guo, Xiaofan
    Sun, Yinxian
    Li, Guangxiao
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (10) : 917 - 927
  • [43] Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019
    Cieza, Alarcos
    Causey, Kate
    Kamenov, Kaloyan
    Hanson, Sarah Wulf
    Chatterji, Somnath
    Vos, Theo
    LANCET, 2020, 396 (10267): : 2006 - 2017
  • [44] The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
    Khanh Bao Tran
    Lang, Justin J.
    Compton, Kelly
    Xu, Rixing
    Acheson, Alistair R.
    Henrikson, Hannah Jacqueline
    Kocarnik, Jonathan M.
    Penberthy, Louise
    Aali, Amirali
    Abbas, Qamar
    Abbasi, Behzad
    Abbasi-Kangevari, Mohsen
    Abbasi-Kangevari, Zeinab
    Abbastabar, Hedayat
    Abdelmasseh, Michael
    Abd-Elsalam, Sherief
    Abdelwahab, Ahmed Abdelwahab
    Abdoli, Gholamreza
    Abdulkadir, Hanan Abdulkadir
    Abedi, Aidin
    Abegaz, Kedir Hussein
    Abidi, Hassan
    Aboagye, Richard Gyan
    Abolhassani, Hassan
    Absalan, Abdorrahim
    Abtew, Yonas Derso
    Ali, Hiwa Abubaker
    Abu-Gharbieh, Eman
    Achappa, Basavaprabhu
    Acuna, Juan Manuel
    Addison, Daniel
    Addo, Isaac Yeboah
    Adegboye, Oyelola A.
    Adesina, Miracle Ayomikun
    Adnan, Mohammad
    Adnani, Qorinah Estiningtyas Sakilah
    Advani, Shailesh M.
    Afrin, Sumia
    Afzal, Muhammad Sohail
    Aggarwal, Manik
    Ahinkorah, Bright Opoku
    Ahmad, Araz Ramazan
    Ahmad, Rizwan
    Ahmad, Sohail
    Ahmadi, Sepideh
    Ahmed, Haroon
    Ahmed, Luai A.
    Ahmed, Muktar Beshir
    Rashid, Tarik Ahmed
    Aiman, Wajeeha
    LANCET, 2022, 400 (10352): : 563 - 591
  • [45] Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019
    Zhu, Shijie
    Zhang, Faxue
    Zhao, Gaichan
    Zhang, Xupeng
    Zhang, Xiaowei
    Li, Tianzhou
    Hu, Chuanwei
    Zhu, Wei
    Li, Dejia
    ORAL ONCOLOGY, 2022, 134
  • [46] The global burden and associated factors of ovarian cancer in 1990-2019: findings from the Global Burden of Disease Study 2019
    Zhang, Shiwen
    Cheng, Chen
    Lin, Zejian
    Xiao, Linzi
    Su, Xin
    Zheng, Lu
    Mu, Yingjun
    Liao, Minqi
    Ouyang, Ruiqing
    Li, Wanlin
    Ma, Junrong
    Cai, Jun
    Liu, Lu
    Wang, Donghong
    Zeng, Fangfang
    Liu, Jun
    BMC PUBLIC HEALTH, 2022, 22 (01) : 1455
  • [47] The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019
    Jiang, Wenkai
    Xiang, Caifei
    Du, Yan
    Li, Xin
    Zhou, Wence
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (02)
  • [48] Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study
    Sun, Yi
    Chen, Aiming
    Zou, Minjie
    Liu, Zhenzhen
    Young, Charlotte Aimee
    Zheng, Danying
    Jin, Guangming
    CLINICAL EPIDEMIOLOGY, 2022, 14 : 827 - 834
  • [49] The burden of suicide in Brazil: findings from the Global Burden of Disease Study 2019
    Costa Bonadiman, Cecilia Silva
    Naghavi, Mohsen
    Souto Melo, Ana Paula
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2022, 55
  • [50] The burden of suicide in Brazil: findings from the Global Burden of Disease Study 2019
    Costa Bonadiman, Cecilia Silva
    Naghavi, Mohsen
    Souto Melo, Ana Paula
    ENGENHARIA AGRICOLA, 2022, 55